ES2379181T3 - Procedimiento para la preparación de adamantanaminas - Google Patents

Procedimiento para la preparación de adamantanaminas Download PDF

Info

Publication number
ES2379181T3
ES2379181T3 ES06003477T ES06003477T ES2379181T3 ES 2379181 T3 ES2379181 T3 ES 2379181T3 ES 06003477 T ES06003477 T ES 06003477T ES 06003477 T ES06003477 T ES 06003477T ES 2379181 T3 ES2379181 T3 ES 2379181T3
Authority
ES
Spain
Prior art keywords
acid
formula
process according
compound
adamantanamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06003477T
Other languages
English (en)
Spanish (es)
Inventor
Christian Schickaneder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Application granted granted Critical
Publication of ES2379181T3 publication Critical patent/ES2379181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES06003477T 2006-02-21 2006-02-21 Procedimiento para la preparación de adamantanaminas Expired - Lifetime ES2379181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06003477A EP1820792B1 (en) 2006-02-21 2006-02-21 Process for the preparation of adamantanamines

Publications (1)

Publication Number Publication Date
ES2379181T3 true ES2379181T3 (es) 2012-04-23

Family

ID=36754153

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06003477T Expired - Lifetime ES2379181T3 (es) 2006-02-21 2006-02-21 Procedimiento para la preparación de adamantanaminas

Country Status (13)

Country Link
US (1) US20090082596A1 (https=)
EP (1) EP1820792B1 (https=)
JP (1) JP5235683B2 (https=)
CN (1) CN101389594B (https=)
AT (1) ATE541827T1 (https=)
AU (1) AU2007218140B2 (https=)
CA (1) CA2640127C (https=)
DK (1) DK1820792T3 (https=)
ES (1) ES2379181T3 (https=)
PL (1) PL1820792T3 (https=)
PT (1) PT1820792E (https=)
SI (1) SI1820792T1 (https=)
WO (1) WO2007096124A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1908748A1 (en) 2006-10-05 2008-04-09 Krka Process for the preparation of memantine and its hydrochloric acid salt form
WO2010007351A1 (en) * 2008-07-14 2010-01-21 Cipla Limited Process for the preparation of memantine and its salts and intermediate for use therein
CN101560157B (zh) * 2009-06-02 2013-09-18 王彦明 盐酸金刚烷胺生产工艺及其专用设备
CN102070463A (zh) * 2009-06-11 2011-05-25 辽宁利锋科技开发有限公司 具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用
JP5749260B2 (ja) * 2009-06-29 2015-07-15 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー ネラメキサンの製造方法
HRP20130485T1 (en) * 2009-06-29 2013-06-30 Merz Pharma Gmbh & Co. Kgaa Method of preparing 1-amino-1,3,3,5,5-pentamethylcyclohexane
HRP20130486T1 (en) * 2009-06-29 2013-06-30 Merz Pharma Gmbh & Co. Kgaa Method of preparing neramexane
EP2448911A1 (en) * 2009-06-29 2012-05-09 Merz Pharma GmbH & Co. KGaA Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
CN101993377A (zh) * 2009-08-07 2011-03-30 出光兴产株式会社 具有金刚烷骨架的胺类和季铵盐的制造方法
CN104936942A (zh) * 2013-01-23 2015-09-23 三菱瓦斯化学株式会社 美金刚胺的制造工艺
CN103483205B (zh) * 2013-10-12 2015-02-04 合肥久诺医药科技有限公司 一种高纯度盐酸美金刚的制备方法
CN103524353B (zh) * 2013-10-12 2015-03-25 合肥久诺医药科技有限公司 一种高纯度盐酸美金刚的制备方法
CN104693039B (zh) * 2015-01-06 2016-11-16 中山大学 一种金刚烷胺类衍生物及其制备方法和应用
CN105399636A (zh) * 2015-12-18 2016-03-16 天津民祥生物医药股份有限公司 一种利用盐酸金刚烷胺制备金刚烷胺游离胺的工艺
CN117843492A (zh) * 2023-12-04 2024-04-09 四川众邦新材料股份有限公司 金刚烷胺生产中的产物分离提取方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391142A (en) 1966-02-09 1968-07-02 Lilly Co Eli Adamantyl secondary amines
ES413944A1 (es) * 1972-04-20 1976-06-01 Merz & Co Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5.
DE2318461A1 (de) 1973-04-12 1974-10-31 Merz & Co Verfahren zur herstellung von 1,3,5trisubstituierten adamanta-verbindungen
SU805609A1 (ru) * 1979-10-12 1981-09-30 Предприятие П/Я В-2343 S-(1-адамантилкарбпмоилметил) изотиуроний хлорид,обладающий антивирусной активностью
ES2059602T3 (es) 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
CZ288445B6 (en) 1996-06-20 2001-06-13 Lachema Np Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane
GB0001093D0 (en) 2000-01-19 2000-03-08 F2 Chemicals Ltd Selective nitrogen functionalisation of organic compounds
GB0018272D0 (en) * 2000-07-25 2000-09-13 Vernalis Research Limited Chemical compounds IV
JP4118555B2 (ja) * 2001-12-13 2008-07-16 株式会社トクヤマ Ｎ−（アダマンチル）アミド化合物の製造方法
RU2246482C2 (ru) 2002-12-25 2005-02-20 ООО "Циклан" Способ получения гидрохлорида 1-амино-3,5-диметиладамантана
CN1240668C (zh) 2003-09-10 2006-02-08 上海医药工业研究院 一种新的盐酸美金刚制备方法
WO2005062724A2 (en) * 2003-12-31 2005-07-14 Sun Pharmaceutical Industries Limited Novel process for the preparation of aminoadamantane derivatives
EP1708707A1 (en) * 2004-01-22 2006-10-11 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
US7456224B2 (en) * 2004-04-05 2008-11-25 Forest Laboratories Holdings, Ltd. Method for treating autism
EP1879849A1 (en) * 2005-05-11 2008-01-23 Dr. Reddy's Laboratories, Inc. Process for preparing memantine

Also Published As

Publication number Publication date
CN101389594A (zh) 2009-03-18
EP1820792A1 (en) 2007-08-22
AU2007218140B2 (en) 2010-08-19
AU2007218140A1 (en) 2007-08-30
JP5235683B2 (ja) 2013-07-10
EP1820792B1 (en) 2012-01-18
CA2640127A1 (en) 2007-08-30
WO2007096124A1 (en) 2007-08-30
CA2640127C (en) 2015-08-11
US20090082596A1 (en) 2009-03-26
PT1820792E (pt) 2012-04-10
CN101389594B (zh) 2013-06-12
ATE541827T1 (de) 2012-02-15
PL1820792T3 (pl) 2012-06-29
JP2009527517A (ja) 2009-07-30
DK1820792T3 (da) 2012-04-10
SI1820792T1 (sl) 2012-04-30

Similar Documents

Publication Publication Date Title
CA2640127C (en) Process for the preparation of adamantanamines
US8420858B2 (en) Process for preparation of iopromide
WO1999001420A1 (en) Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process
CN105130926B (zh) 一种亚甲基蓝的制备方法
JP2011513286A (ja) コンブレタスタチンの調製方法
EP2723709A1 (en) Manufacture of a triiodinated contrast agent
US8598370B2 (en) Process for producing threo-3-(3,4-dihydroxyphenyl)-L-serine
PT95097B (pt) Processo aperfeicoado para a preparacao de amino acidos ciclicos
JP2025061453A (ja) １，５－ベンゾチアゼピン化合物を製造するための方法
JP2008531642A (ja) 薬学活性化合物イルベサルタンおよびその合成中間体を得る方法
CN103562207B (zh) 用于制备缬更昔洛韦的2-氨基-9-((2-苯基-1，3-二噁烷-5-基氧基)甲基)-1h-嘌呤-6(9h)-酮化合物的制备方法
CN114605331A (zh) 一种尼鲁米特及其中间体的制备方法
EP3260442B1 (en) Process for preparation of optically pure n-substituted-3-methoxypropionic acid derivatives
JP4356111B2 (ja) Ｎ−（２−アミノ−１，２−ジシアノビニル）ホルムアミジンの製造方法
CN105636933A (zh) 制备碘普罗胺的中间体的方法
HK1129365A (en) Process for the preparation of adamantanamines
CN108440374A (zh) 一种阿西美辛的制备方法
TW202311275A (zh) 烷基矽烷氧取代苄基化合物之製造方法
CN119823170A (zh) 维贝格隆中间体化合物及其制备方法和应用
WO2023102800A1 (en) Synthesis of 5, 7-dichloro-1, 6-naphthyridine
TW202419441A (zh) 烷基矽烷氧取代苄胺化合物之製造方法
CN120943782A (zh) 一种吡唑醚类化合物的制备方法
CN119977967A (zh) N-甲基-n-苄基-n′-(6-氯-6,9-二氢-1h-嘌呤-2-基)甲脒化合物及其制备和应用
KR20090010546A (ko) 가바펜틴의 제조 방법 및 중간체
JP2004307408A (ja) Ｎ６−アシル化デオキシアデノシン誘導体の製造法